<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI-
TIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 1996
--------------------------------------------
OR
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURI-
TIES EXCHANGE ACT OF 1934
For the transition period from to
------------------- ----------------------
Commission file number 1-11654
-----------------------------------
Health Images, Inc.
- ---------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 58-1485618
- ---------------------------------------------------------------------------
(State or other jurisdiction of (I.R.S. Employee Identification No.)
incorporation or organization)
8601 Dunwoody Place, Bldg. 200, Atlanta, Georgia 30350
- ----------------------------------------------------------------------------
(Address of principal executive offices) (Zip code)
Registrant's telephone number, including area code 770/587-5084
-------------------------
- ----------------------------------------------------------------------------
Former name, former address and former fiscal year, if changed since
last report
Indicate by check X whether the registrant (1) has filed all
reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such
shorter period that the registrant was required to file such re-
ports), and (2) has been subject to such filing requirements for the
past 90 days Yes X No
APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY
PROCEEDINGS DURING THE PRECEDING FIVE YEARS:
Indicate by check mark whether the registrant has filed all
documents and reports required to be filed by Section 12, 13 or 15(d)
of the Securities Exchange Act of 1934 subsequent to the distribution
of securities under a plan confirmed by a court. Yes No
APPLICABLE ONLY TO CORPORATE ISSUERS:
Indicate the number of shares outstanding of each of the
issuer's classes of common stock, as of the latest practicable date
11,477,364.
<PAGE>
HEALTH IMAGES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
AS OF SEPTEMBER 30, 1996
<TABLE>
<CAPTION>
ASSETS SEPTEMBER 30, DECEMBER 31,
1996 1995
------------- ------------
<S> <C> <C>
CURRENT ASSETS
Cash and Cash Equivalents $ 3,073,000 $ 3,204,700
Marketable Securities - 267,400
Trade Receivables (Less Allowance
for Doubtful Accounts and Discounts of
$10,738,200 in 1996, and $10,565,200
in 1995) 28,007,300 24,537,600
Other Receivables 265,800 806,700
Inventories 320,700 316,500
Deferred Income Taxes 2,941,800 2,826,800
Other 2,652,600 2,187,600
------------ ------------
Total Current Assets 37,261,200 34,147,300
------------ ------------
PROPERTY AND EQUIPMENT
Total Property and Equipment 170,692,800 155,103,800
Accumulated Depreciation 69,654,600 60,647,700
------------ ------------
Cost Less Accumulated Depreciation 101,038,200 94,456,100
------------ ------------
OTHER ASSETS
Intangible Assets 45,847,700 47,058,700
Unclassified 1,095,200 650,300
------------ ------------
Total Other Assets 46,942,900 47,709,000
------------ ------------
TOTAL ASSETS $185,242,300 $176,312,400
============ ============
LIABILITIES AND STOCKHOLDERS' EQUITY
CURRENT LIABILITIES
Current Portion of Long Term Debt $16,227,400 $16,352,500
Accounts Payable 9,047,300 9,369,400
Accrued Expenses 11,161,800 8,450,700
Unearned Revenue 418,800 135,500
------------ ------------
Total Current Liabilities 36,855,300 34,308,100
------------ ------------
LONG TERM DEBT 45,803,600 45,000,500
------------ ------------
DEFERRED INCOME TAXES 11,200,900 11,711,300
------------ ------------
OTHER LONG TERM LIABILITIES 258,900 245,700
----------- ------------
MINORITY INTEREST 1,684,800 1,258,100
----------- ------------
STOCKHOLDERS' EQUITY
Common Stock-$.01 Par Value-40,000,000
Shares Authorized-13,458,885 Shares
issued as of September 30, 1996, and
13,380,052 as of December 31, 1995 134,600 133,800
Additional Paid-In Capital 78,157,100 77,674,400
Retained Earnings 27,127,500 21,288,000
Accumulated Translation Adjustment (373,700) (508,700)
Treasury Stock - 2,040,762 Shares at
Cost as of September 30, 1996, and
1,957,300 as of December 31, 1995 (15,606,700) (14,798,800)
------------ ------------
Total Stockholders' Equity 89,438,800 83,788,700
----------- -----------
TOTAL LIABILITIES AND STOCKHOLDERS'
EQUITY $185,242,300 $176,312,400
============ ============
</TABLE>
<PAGE>
HEALTH IMAGES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF OPERATIONS
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1996
<TABLE>
<CAPTION>
THREE MONTHS NINE MONTHS NINE MONTHS NINE MONTHS
ENDED ENDED ENDED ENDED
SEPTEMBER 30, SEPTEMBER 30, SEPTEMBER 30 SEPTEMBER 30,
1996 1995 1996 1995
------------- ------------- ------------- -------------
<S> <C> <C> <C> <C>
REVENUE
Net Patient Service Revenue $33,706,500 $32,075,300 $ 95,999,000 $80,585,200
Engineering Revenue 864,000 561,800 1,756,500 2,140,200
Other Revenue & Income 228,100 133,500 1,223,300 589,700
------------ ----------- ----------- ----------
Total Net Revenue $34,798,600 $32,770,600 $98,978,800 $83,315,100
------------ ----------- ----------- -----------
COSTS AND EXPENSES
Operating Costs 21,320,200 19,735,500 60,802,600 50,292,800
Depreciation and Amortization
Expenses 4,538,800 4,741,200 13,538,500 12,866,400
Provision for Bad Debts 1,154,500 1,310,000 3,630,700 3,332,600
General and Administrative Expenses 2,685,300 2,421,900 6,942,600 5,685,700
----------- ----------- ------------ -----------
Total Operating Expenses 29,698,800 28,208,600 84,914,400 72,177,500
----------- ----------- ------------ -----------
Operating Income 5,099,800 4,562,000 14,064,400 11,137,600
Interest Income 20,000 30,200 63,900 101,400
Interest Expense (1,020,100) (1,123,600) (2,880,700) (2,731,200)
------------- ------------ ------------- -----------
INCOME FROM CONTINUING OPERATIONS
BEFORE MINORITY INTEREST AND
PROVISION FOR INCOME TAXES 4,099,700 3,468,600 11,247,600 8,507,800
Minority Interest in Income of
Consolidated Entities 225,600 272,500 593,100 493,700
------------ ----------- ----------- ---------
INCOME FROM CONTINUING OPERATIONS BEFORE
PROVISION FOR INCOME TAXES 3,874,100 3,196,100 10,654,500 8,014,100
Provision For Income Taxes 1,438,100 1,249,700 3,957,700 3,112,900
------------ ------------ ---------- ----------
NET INCOME FROM CONTINUING OPERATIONS $2,436,000 $1,946,400 $6,696,800 $4,901,200
=========== =========== ========== ==========
DISCONTINUED OPERATIONS
Loss on Discontinued Operations
(Net of Income Taxes) -- 1,100 -- 419,100
Loss on Disposal of Discontinued
Operations (Net of Income Taxes) -- -- -- 744,000
--------- --------- ---------- --------
NET INCOME $2,436,000 $1,945,300 $6,696,800 $3,738,100
========== ========== ========== ==========
EARNINGS PER COMMON AND COMMON
EQUIVALENT SHARE
Primary Earnings Per Share
Primary Net Income from Continuing
Operations Per Share $0.21 $0.17 $0.57 $0.42
Discontinued Operations Per Share -- -- -- ($0.10)
Primary Net Income Per Share $0.21 $0.17 $0.57 $0.32
Fully Diluted Earnings Per Share
Fully Diluted Net Income
from Continuing Operations Per Share $0.21 $0.17 $0.56 $0.42
Discontinued Operations Per Share -- -- -- ($0.10)
Fully Diluted Net Income Per Share $0.21 $0.17 $0.56 $0.32
WEIGHTED AVERAGE COMMON SHARE AND
COMMON SHARE EQUIVALENTS
Primary 11,761,300 11,540,900 11,698,700 11,587,100
Fully Diluted 11,853,100 11,579,800 11,854,700 11,657,300
</TABLE>
<PAGE>
HEALTH IMAGES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOW
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 1996
<TABLE>
<CAPTION>
THREE MONTHS THREE MONTHS NINE MONTHS NINE MONTHS
ENDED ENDED ENDED ENDED
SEPTEMBER 30, SEPTEMBER 30, SEPTEMBER 30 SEPTEMBER 30,
1996 1995 1996 1995
------------- ------------- ------------- -------------
<S> <C> <C> <C> <C>
CASH FLOW FROM OPERATING ACTIVITIES
Net Income $2,436,000 $1,945,300 $6,696,800 $3,738,100
Adjustments to Reconcile Net
Income to Net Cash
Depreciation 3,817,300 3,319,000 11,166,100 9,423,400
Amortization 759,200 1,422,000 2,372,400 3,443,000
Provision for Bad Debt 1,154,500 1,310,000 3,630,700 3,332,600
Minority Interest 225,600 272,500 593,100 493,700
Deferred Income Taxes (232,800) (118,700) (625,400) (11,300)
Increase in Receivables (3,609,300) (2,494,000) (6,559,500) (4,698,900)
Decrease (Increase) in Inventories (11,100) (202,000) (4,200) (136,300)
Increase (Decrease) in Accounts
Payable and Accrued Expenses 2,131,600 3,507,300 2,809,000 5,742,800
Currency Exchange Loss -- -- -- 257,300
Gain on Sale of Property and
Equipment -- -- -- (329,600)
Other - Net 56,700 (169,800) (181,700) (296,500)
---------- ---------- ---------- ---------
Net Cash Provided by Operating
Activities 6,727,700 8,791,600 19,897,300 20,958,300
---------- ---------- ---------- ----------
CASH FLOW FROM INVESTING ACTIVITIES
Cash Used to Acquire Investments -- -- (773,500) (56,700)
Proceeds from Investments -- -- 1,040,900 281,000
Capital Expenditures (7,593,600) (3,486,100) (17,613,200) (7,669,600)
Acquisitions of Imaging Facilities -- -- -- (22,752,600)
Proceeds from Sale of Assets -- 261,800 -- 1,251,000
Payments for Intangibles (209,500) (141,500) (1,161,400) (1,449,900)
Other - Net (444,900) 100 (483,900) (8,400)
---------- ---------- ---------- ----------
Net Cash Used by Investing Activities (8,248,000) (3,365,700) (18,991,100) (30,405,200)
---------- ---------- ------------ ------------
<PAGE>
CASH FLOW FROM FINANCING ACTIVITIES
Proceeds from Issuing Notes
Payable 6,336,000 -- 11,807,700 30,000,000
Cash Used to Retire Debt (3,908,000) (3,912,700) (11,129,700) (19,472,100)
Cash Distributions to Minority
Investors in Limited Partnerships (71,900) (50,200) (127,400) (145,200)
Proceeds from Exercise of Stock
Options 340,800 5,400 462,700 14,200
Cash Used to Pay Dividends (285,800) (229,800) (857,300) (693,400)
Cash Used to Purchase Treasury
Shares (675,400) (648,900) (1,214,700) (1,136,900)
Other - Net (29,200) 145,100 20,800 145,000
---------- ---------- ---------- ----------
Net Cash (Used) Provided by
Financing Activities 1,706,500 (4,691,200) (1,037,900) 8,711,600
---------- ----------- ----------- ---------
EFFECT OF EXCHANGE RATE CHANGES
ON CASH -- (13,000) -- 28,400
---------- ---------- ---------- ---------
INCREASE (DECREASE) IN CASH AND
CASH EQUIVALENTS 186,200 721,700 (131,700) (706,900)
CASH AND CASH EQUIVALENTS -
BEGINNING OF PERIOD 2,886,800 2,375,500 3,204,700 3,804,100
---------- ---------- ---------- ----------
CASH AND CASH EQUIVALENTS -
END OF PERIOD $3,073,000 $3,097,200 $3,073,000 $3,097,200
========== ========== ========== ==========
SUPPLEMENTAL SCHEDULE OF NONCASH
INVESTING AND FINANCING ACTIVITIES
Treasury Stock Reissued in
Conjunction with Employee
Benefit Plans $59,400 -- $ 406,800 --
Assumption of Liabilities in
Conjunction with Acquisition -- -- -- $31,546,900
Redemption of Preferred Stock in
Conjunction with Acquisition -- -- -- $11,569,300
SUPPLEMENTAL SCHEDULE OF CASH FLOWS
Cash Paid for Interest $1,230,200 $1,351,900 $3,782,800 $3,210,400
Cash Paid for Income Taxes $951,800 $1,008,000 $3,768,700 $1,509,400
</TABLE>
<PAGE>
PART I MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
Results of Operations
Comparison of the quarter ended September 30, 1996, to the quarter
ended September 30, 1995.
Net patient service revenue increased $1,631,200, or 5.1%,
primarily due to an increase in net revenue at imaging centers that
were in operation for both the 1995 and 1996 periods ("same center
revenue") of $1,745,800, or 5.5%, partially offset by the disposition
of three imaging centers during the prior year period.
Engineering revenue increased $302,200, or 53.8%, primarily due
to an increase in upgrade revenue of $450,000, partially offset by
lower service revenue. Service revenue is likely to continue to
decrease in future periods and future upgrade revenue, if any, is
likely to be intermittent.
Other revenue and income increased $94,600, or 70.9%, primarily
due to higher management fee income from a managed MRI center.
Operating costs increased by $1,584,700, or 8.0%, primarily due
to increased expenses associated with higher patient volumes, offset
by the elimination of costs associated with the three disposed
centers. Depreciation and amortization expenses decreased by
$202,400, or 4.3%, due to purchase price allocation adjustments
related to the MedAlliance centers acquisition and the elimination of
depreciation and amortization charges related to the disposed
centers. The Company's provision for bad debts was $1,154,500, or
3.4% of net patient service revenue in the 1996 period as compared to
$1,310,000, or 4.1%, in 1995. Provisions for bad debt result from
required write-offs of accounts management deems to be uncollectible.
Management expects future bad debt experience to be comparable to
these results. General and administrative expenses increased
$263,400, or 10.9%, due to $462,600 of legal expenses related to an
arbitration procedure arising out of the Company's acquisition of
National Diagnostic Systems, Inc.("NDS"), a discontinued
subsidiary, partially offset by cost containment efforts and
realized economies from the MedAlliance centers acquisition. The
Company expects to incur additional legal expenses related to this
arbitration in the fourth quarter of 1996 and the first quarter of
1997. The Company anticipates a ruling in the arbitration by the end
of the 1997 first quarter.
- ----------------------------------
1 Net patient service revenue represents imaging revenue reduced by contractual
adjustments related to discount arrangements with third party payers. Such
discount arrangements are customary in the health care industry and are, in
the opinion of management, necessaary for competitive reasons.
2 The Company originally stated the arbitration expenses that directly relate
to resolving legal issues out of the IDSI Discontinued Operations as a
separate line item classified as a subsequent period "Loss on Disposal of
Discontinued Operations." Because these expenses are being incurred more
than one year following the original IDSI Discontinued Operation charge,
the Company's auditors have recommended that these expenses be reclassified
as general and administrative expenses.
<PAGE>
These costs are not shown as discontinued operations because the costs were
incurred longer than one year from the date of disposal, although all of these
costs are attributable to the discontinued subsidiary. General and
administrative expenses as a percentage of net revenue were 7.7% in the 1996
period as compared to 7.4% in 1995.
Interest income decreased by $10,200, or 33.8%, due to lower
cash balances. Interest expense decreased by $103,500, or 9.2%,due
to negotiation of favorable interest rates on the Company's primary
bank facilities and increased capitalized interest associated with
the manufacture of the Company's HI STAR(R) MRI systems and the
construction of the Company's new headquarters and manufacturing
facility. Minority interest in income of consolidated entities
decreased by $46,900, or 17.2%, primarily due to decreased
profitability at the Company's partnership facilities and the
repurchase of limited partnership units.
Income taxes increased by $188,400, or 15.1%, primarily due to
higher pretax income. Income taxes as a percentage of pretax income
decreased to 37.1% in the 1996 period as compared to 39.1% in the
1995 period due to capital loss carryforwards available in the 1996
period. Management expects the Company's tax rate to approximate
37.2% for the remainder of 1996.
Net income increased $490,700, or 25.2%, to $2,436,000 in the
1996 period from $1,945,300 in 1995. Primary and fully diluted
earnings per share increased $0.04 per share, or 23.5%, to $0.21 in
the 1996 period as compared to $0.17 in 1995. Earnings per share
were calculated using 11,761,300 primary and 11,853,100 fully diluted
weighted average common shares and share equivalents for the 1996
period as compared to 11,540,900 primary and 11,579,800 fully diluted
shares and share equivalents in 1995.
The increased net income and earnings per share recorded by the
Company for the quarter reflect the realization of merger synergies
from the MedAlliance center acquisition, expansion of the services
and modalities offered at its existing imaging centers, and an
improvement in the diagnostic imaging industry. The Company has also
been successful in disposing of certain under performing center
assets. The diagnostic imaging industry, however, continues to be
intensely competitive. The growth of managed care plans continues to
place downward pressure on imaging reimbursements and has resulted in
increased scrutiny of the appropriateness of referrals for major
diagnostic imaging procedures, such as MRI and CT services, which are
the Company's principal sources of revenue. In addition, the Company
may be at a competitive disadvantage to hospitals and hospital
systems which can offer a comprehensive range of health care services
to managed care plans. Management believes, however, that the
Company is relatively better positioned than many of its competitors
because of its lower cost structure, high level of service to
physicians and patients and lack of reliance upon physician self-
referral practices. The Company's vertical integration results in
generally lower equipment and construction costs and significantly
reduced equipment maintenance costs. Management believes that the
new HI STAR(R) MRI system will improve the competitiveness of the
Company's technology at a relatively low marginal cost. The Company
installed the first of these systems in April, 1996 and delivered an
additional three systems during the third quarter of 1996.
Management anticipates manufacturing three additional HI STAR(R) units
during the remainder of 1996. Management also
<PAGE>
believes that certain internal growth opportunities and additional
acquisitions may be available near term.
Comparison of the nine months ended September 30, 1996, to the nine
months ended September 30, 1995.
Net patient service revenue increased $15,413,800, or 19.1%,
primarily due to the MedAlliance center acquisition effective April
1, 1995, and an increase in same center revenue of $3,893,000, or
5.0%, partially offset by the disposition of three imaging centers.
Engineering revenue decreased $383,700, or 17.9%, primarily due to
decreased service revenue.
Other revenue and income increased $633,600, or 107.4%. This
increase is primarily due to realized capital gains on marketable
securities and an increase in management fee income from the
Company's managed MRI center.
Operating costs increased by $10,509,800, or 20.9%, primarily
due to increased expenses associated with the MedAlliance centers
acquisition and higher patient volumes, partially offset by the
elimination of costs associated with the three disposed centers.
Depreciation and amortization expenses increased $672,100, or 5.2%,
primarily due to the MedAlliance center acquisition. The Company's
provision for bad debts was $3,630,700 or 3.8% of net patient
services revenue in the 1996 period as compared to $3,332,600 or 4.1%
in 1995. General and administrative expenses increased $1,256,900 or
22.0%, primarily due to additional expenses related to the
MedAlliance centers acquisition and $462,600 of legal expenses
related to an arbitration procedure arising out of the Company's
acquisition of National Diagnostic Systems, Inc.("NDS"), a
discontinued subsidiary. The Company expects to incur additional
legal expenses related to this arbitration in future periods. These
costs are not shown as discontinued operations because the costs were
incurred longer than one year from the date of disposal, although all
of these costs are attributable to the discontinued subsidiary.
General and Administrative expenses as a percentage of net revenue
were 7.0% in the 1996 period as compared to 6.8% in 1995.
Interest income decreased by $37,500, or 37.0%, due to lower
cash balances. Interest expense increased by $149,500, or 5.5%, due
to debt incurred in conjunction with the MedAlliance clinic
acquisition, partially offset by negotiation of favorable interest
rates on the Company's primary bank facilities and increased
capitalized interest associated with the manufacture of the Company's
HI STAR(R) MRI systems. Minority interest in income of consolidated
entities increased by $99,400, or 20.1%, primarily due to minority
interest acquired from MedAlliance and increased profitability at the
Company's partnership centers.
Income taxes increased by $1,016,700, or 32.7%, primarily due to
higher pretax income. Income taxes as a percentage of pretax income
decreased to 37.2% in the 1996 period as compared to 38.8% in the
1995 period due to capital loss carryforwards available in 1996.
Management expects the Company's tax rate to approximate 37.2% for
the remainder of 1996.
<PAGE>
Net income from continuing operations increased $1,795,600, or
36.6%, to $6,696,800 in the 1996 period from $4,901,200 in 1995.
Primary earnings per share from continuing operations increased
$0.15, or 35.7%, to $0.57 in the 1996 period as compared to $0.42 in
1995. Fully diluted earnings per share from continuing operations
increased $0.14 per share, or 33.3%, to $0.56 in the 1996 period as
compared to $0.42 in 1995.
In the prior year period, the Company reported a $744,000 net
after tax loss on disposal of NDS, its discontinued subsidiary. In
the 1995 period, the Company also reported a net after tax loss of
$419,100 from operations of the discontinued subsidiary.
The 1996 results charge reflect $462,600 of legal expenses
related to an arbitration proceeding arising out of the Company's
acquisition of and disposition of the discontinued subsidiary. The
Company expects to record additional legal expenses related to this
matter in future periods.
Primary earnings per share increased $0.25, or 78.1%, to $0.57
in the 1996 period as compared to $0.32 in 1995. Fully diluted
earnings per share increased $0.24, or 75.0%, to $0.56 in the 1996
period as compared to $0.32 in 1995. Earnings per share were
calculated using 11,698,700 primary and 11,854,700 fully diluted
weighted average common share equivalents for the 1996 period as
compared to 11,587,100 primary and 11,657,300 fully diluted share
equivalents in 1995.
Inflation
The impact of inflation and changing prices on the Company has,
to date, been primarily limited to salary increases and has not been
material to the Company's operation. In the event of increased
inflation, management believes that the Company may not be able to
raise the prices for its goods and services by an amount sufficient
to offset cost inflation.
Management believes that reimbursements for its services will
continue to decline in the future, even in an otherwise inflationary
environment. The rate of decline in reimbursement levels, however, has slowed
recently and may indicate some pricing stabilization. The Company
has historically responded to reimbursement declines by lowering its
capital costs and by increasing the volume of its business.
Liquidity and Capital Resources
Net cash provided by operating activities was $19,897,300 for
the nine months ended September 30, 1996, a decrease of $1,061,000,
or 5.1%, from $20,958,300 in the prior year period. This decrease is
primarily due to increases in the Company's accounts receivable
balances and decreases in current liabilities, partially offset by
increased levels of net income and non-cash depreciation and
amortization expenses. Net trade receivables increased by $3,469,700
to $28,007,300 during the nine months ended September 30, 1996,
primarily due to increased patient revenue. As of September 30,
1996, the Company's average age of patient receivables was 75 days as
compared to 73 days as of June 30, 1995, 74 days as of December 31,
1995 and 77 days as of September 30, 1995. Management believes this
average age of patient receivables to be within industry norms and
significantly better than many of its competitors.
<PAGE>
The Company increased net outstanding debt by $678,000 during
the nine months ended September 30, 1996, to $62,031,000. Cash and
cash equivalents decreased by $131,700 for the nine months ended
September 30, 1996, to $3,073,000.
The Company had available $4,536,500 under its $12,000,000
bank line at September 30, 1996. During the nine months ended
September 30, 1996, the Company borrowed $1,690,500 to finance the
purchase of medical equipment used in the expansion of its center
business and $3,193,800 to finance the ongoing construction of its
new corporate offices.
Capital expenditures for the nine months ended September 30,
1996 were $17,613,200. The principal capital expenditures for the
remainder of 1996 will be purchases and construction of imaging
equipment, upgrades and enhancements for the Company's HI Standard(R)
and HI STAR(R) MRI systems, the expansion and upgrading of certain of
the Company's existing imaging facilities and the completion of the
construction of the Company's new corporate headquarters and
manufacturing facility.
Management considers current cash and liquidity, together with
cash flows from operating activities, adequate to fund the Company's
existing business operations and the Company's intended short term
capital expenditure and expansion plans. Additional capital may be
required in the future to fund long term growth, and management
believes such financing is readily available from several sources.
At September 30, 1996, the Company had outstanding commitments
of $5,876,300 on equipment and construction contracts.
Subsequent Events
On October 30, 1996, the Company entered into a new bank
credit facility (the "facility") with its principal lending banks.
The facility provides for a term loan of $50,000,000 and a revolving
line of credit of $15,000,000. The facility bears an interest rate
varying between prime plus one quarter (1/4) percent to prime minus
one half (1/2) percent, dependent on certain financial ratios. The
facility further provides that principal repayments on the term loan
increase dollar-to-dollar credit availabilities up to a maximum of
$45,000,000 on the revolving line of credit. The Company expects to
use approximately $45,000,000 of the term loan to repay existing debt
with the balance of $5,000,000 to be used to fund working capital and
capital expenditure requirements. The facility is secured by a
pledge of the Company's otherwise unencumbered real and personal
property. The facility requires the Company to maintain certain
financial ratios related to liquidity, tangible capital, and debt
service. The facility also imposes a yearly cap on capital
expenditures.
On October 25, 1996 the Company filed with the Securities and
Exchange Commission a registration statement on Form S-3 related to a
proposed public offering of 2,500,000 additional common shares.
Forward Looking Statements
Statements contained in this 10-Q which are not historical facts
are forward-looking statements. Such forward-looking statements are
estimates reflecting management's best
<PAGE>
judgement based on information currently available and involve a number of
risks and uncertainties. Additionally, there can be no assurance that other
factors will not affect the accuracy of such forward-looking statements.
While it is impossible to identify all such factors, factors which could cause
actual results to vary materially from those estimated by the Company
include, but are not limited to, changes in federal and state
regulation of the health care industry, changes in reimbursements by
governmental and private payors, changes in medical device
regulation, technological innovation in the diagnostic imaging
industry and the Company's ability to respond to such innovation, the
Company's ability to obtain acceptable arrangements with such third-
party payors, changes in competitive pressures in the health care
industry, general conditions in the economy and the capital markets,
and other factors which may be identified from time to time in the
Company's Securities and Exchange Commission filings and other public
announcements.
<PAGE>
PART II. OTHER INFORMATION
ITEM 1. Legal Proceedings.
During the quarter ended September 30, 1996, the Company
and its Chairman, President and CEO, Robert D. Carl, III
resolved all claims in the federal and state actions
brought against each of them by Pamela C. Smith, a former
employee of the Company. The terms of the litigation
resolution were stipulated by all parties to be
confidential. The amount involved in the resolution,
however, was substantially less than ten percent (10%) of
the Company's current assets on a consolidated basis.
In the California arbitration involving the Company's
claims against the selling shareholders of National
Diagnostic Systems, Inc. ("NDS") and the selling
shareholders claims against the Company, the arbitrator
began hearing evidence in September 1996. The arbitration
is scheduled to resume in November 1996.
ITEM 2. Changes in Securities.
None.
ITEM 3. Defaults under Senior Securities.
None.
ITEM 4. Submission of Matters to a Vote of Security Holders.
None.
ITEM 5. Other Information.
None.
ITEM 6. Exhibits and Reports on Form 8-K.
a. Exhibits required to be filed by Item 601 of Regu-
lation S-K are included as Exhibits to this report as
follows:
Exhibit
Number
-------
4 -- Instruments defining rights of security
holders are incorporated herein by reference
to Exhibit 4(c) included in Registrant's
Annual Reports on Form 10-K for fiscal year
ended December 31, 1987; to Exhibit 10(b) to
Registrant's Annual Report on Form 10-K for
fiscal year ended December 31, 1988; to
Exhibit 1 to Registrant's Form 8-K filed
June
<PAGE>
20, 1989 and to Exhibits 3(a) and 3(b)
to Registrant's Annual Report on Form 10-K
for fiscal year ended December 31, 1989.
b. Reports on Form 8-K -- The following reports on Form
8-K have been filed by Registrant during the quarter
ended September 30, 1996:
None.
<PAGE>
EXHIBIT INDEX
Exhibit Page
Number Description Number
- ------- ----------- ------
27 -- Financial Data Schedule
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
HEALTH IMAGES, INC.
(Registrant)
Date: November 1, 1996 By:/s/Robert D. Carl, III
----------------------
Robert D. Carl, III
Chairman, President and
Chief Executive Officer
By:/s/Ron L. Clark
---------------
Ron L. Clark
Treasurer and Controller
(Principal Accounting
Officer)
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the Registrant has duly caused this report to be signed
on its behalf by the undersigned thereunto duly authorized.
HEALTH IMAGES, INC.
(Registrant)
Date: November 1, 1996 By:/s/Robert D. Carl, III
----------------------
Robert D. Carl, III
Chairman, President and
Chief Executive Officer
By:/s/ Ron L. Clark
----------------
Ron L. Clark
Treasurer and Controller
(Principal Accounting
Officer)
<TABLE> <S> <C>
<ARTICLE> 5
<MULTIPLIER> 1
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1995
<PERIOD-END> SEP-30-1996
<CASH> 3,073,000
<SECURITIES> 0
<RECEIVABLES> 28,007,300
<ALLOWANCES> 10,738,200
<INVENTORY> 320,700
<CURRENT-ASSETS> 37,261,200
<PP&E> 101,038,200
<DEPRECIATION> 69,654,600
<TOTAL-ASSETS> 185,242,300
<CURRENT-LIABILITIES> 36,855,300
<BONDS> 0
0
0
<COMMON> 134,600
<OTHER-SE> 0
<TOTAL-LIABILITY-AND-EQUITY> 185,242,300
<SALES> 97,755,500
<TOTAL-REVENUES> 98,978,800
<CGS> 0
<TOTAL-COSTS> 84,914,400
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 2,880,700
<INCOME-PRETAX> 10,654,500
<INCOME-TAX> 3,957,700
<INCOME-CONTINUING> 6,696,800
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 6,696,800
<EPS-PRIMARY> .60
<EPS-DILUTED> .59
</TABLE>
